ES2100941T3 - Uso de cromakalim/brl 38227 para el tratamiento de la hiperreactividad de las vias respiratorias. - Google Patents

Uso de cromakalim/brl 38227 para el tratamiento de la hiperreactividad de las vias respiratorias.

Info

Publication number
ES2100941T3
ES2100941T3 ES91900304T ES91900304T ES2100941T3 ES 2100941 T3 ES2100941 T3 ES 2100941T3 ES 91900304 T ES91900304 T ES 91900304T ES 91900304 T ES91900304 T ES 91900304T ES 2100941 T3 ES2100941 T3 ES 2100941T3
Authority
ES
Spain
Prior art keywords
treatment
cromakalim
hyperreactivity
brl
respiratory tract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91900304T
Other languages
English (en)
Inventor
Derek Richard Buckle
John Frank Taylor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Application granted granted Critical
Publication of ES2100941T3 publication Critical patent/ES2100941T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

UN METODO PARA EL TRATAMIENTO Y/O PROFILAXIS DE LA HIPERREACTIVIDAD DE LAS VIAS RESPIRATORIAS EN MAMIFEROS, TALES COMO LOS HUMANOS, CUYO METODO COMPRENDE EL ADMINISTRAR AL MAMIFERO QUE NECESITA TAL TRATAMIENTO Y/O PROFILAXIS UNA CANTIDAD EFECTIVA Y/O PROFILACTICA DE CROMAKALIN/BRL 38227.
ES91900304T 1989-12-11 1990-12-11 Uso de cromakalim/brl 38227 para el tratamiento de la hiperreactividad de las vias respiratorias. Expired - Lifetime ES2100941T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898927980A GB8927980D0 (en) 1989-12-11 1989-12-11 Pharmaceuticals

Publications (1)

Publication Number Publication Date
ES2100941T3 true ES2100941T3 (es) 1997-07-01

Family

ID=10667773

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91900304T Expired - Lifetime ES2100941T3 (es) 1989-12-11 1990-12-11 Uso de cromakalim/brl 38227 para el tratamiento de la hiperreactividad de las vias respiratorias.

Country Status (10)

Country Link
EP (1) EP0471040B1 (es)
AT (1) ATE149832T1 (es)
AU (1) AU7994891A (es)
DE (1) DE69030181T2 (es)
DK (1) DK0471040T3 (es)
ES (1) ES2100941T3 (es)
GB (1) GB8927980D0 (es)
GR (1) GR3023250T3 (es)
IE (1) IE904460A1 (es)
WO (1) WO1991008741A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9124754D0 (en) * 1991-11-21 1992-01-15 Smithkline Beecham Plc Pharmaceuticals
US5646156A (en) * 1994-04-25 1997-07-08 Merck & Co., Inc. Inhibition of eosinophil activation through A3 adenosine receptor antagonism
EP3099304A4 (en) 2014-01-31 2018-01-10 Mayo Foundation for Medical Education and Research Novel therapeutics for the treatment of glaucoma

Also Published As

Publication number Publication date
EP0471040B1 (en) 1997-03-12
ATE149832T1 (de) 1997-03-15
WO1991008741A1 (en) 1991-06-27
DK0471040T3 (da) 1997-04-01
DE69030181D1 (de) 1997-04-17
IE904460A1 (en) 1991-06-19
DE69030181T2 (de) 1997-07-17
AU7994891A (en) 1991-07-18
GB8927980D0 (en) 1990-02-14
EP0471040A1 (en) 1992-02-19
GR3023250T3 (en) 1997-07-30

Similar Documents

Publication Publication Date Title
ATE140388T1 (de) Zusammensetzungen enthaltend omega conotoxin peptide derivate und deren verwendung zur behandlung von ischämie-artigen neuronalen schädigungen
ES2036737T3 (es) Procedimiento para la obtencion de mezclas farmaceuticas.
AR003426A1 (es) Derivados de rapamicina y procedimiento para prepararlos, composiciones farmacéuticas formuladas con dichos derivados y equipos(kits) que incluyen dichos derivados para tratar infecciones,estados inflamatorios o tratamientos inmunosupresores.
ES2107824T3 (es) Procedimiento para el secado subcritico de aerogeles.
ES2074565T3 (es) Empleo de melatonina para tratar el sindrome pre-menstrual.
BR9509498A (pt) Agente aglutinante uso do mesmo composição farmacêutica e processo para tratamento de uma doença inflamatória autoimune ou uma doença alérgica
MX9204078A (es) Metodo y composicion para la prevencion de la enfermedad de lyme.
ES2055406T3 (es) Composicion para el tratamiento de la inflamacion.
MX9205127A (es) Una composicion farmaceutica y un metodo para usar una combinacion de un agente uricosurico y un antagonista eaa.
ES2164088T3 (es) Antagonistas de la sustancia p para el tratamiento de la emesis.
CA2070685A1 (en) Method for treating painful, inflammatory or allergic disorders
ES499227A0 (es) Procedimiento para la determinacion de antigenos carcinoem- brionicos en el plasma humano
ES2057476T3 (es) Medios para el diagnostico de neuropatias desmielinizantes, en particular de la esclerosis en placas.
FI931204A (fi) Nya, saosom lipooxigenasinhibitorer verkande aminobensosultamderivat
TR199900505T2 (es)
ES2100941T3 (es) Uso de cromakalim/brl 38227 para el tratamiento de la hiperreactividad de las vias respiratorias.
NO984760D0 (no) Anvendelse av en osmolytt ved behandling av effekter forÕrsaket av en infeksjon, en inflammasjon eller en immundysfunksjon
ES2063421T3 (es) Componente efervescente y procedimiento para su fabricacion.
ES2194104T3 (es) Uso de selegilina para el tratamiento de la perdida de audicion en mamiferos.
BR9612234A (pt) Composto processo para preparação do mesmo uso do composto e processos para tratamento de doenças das vias aéreas e tratamento ou profilaxia de glaucoma
MX9200018A (es) Procedimento para la preparacion de esteres de sulfoxido de 3- exometilencefam.
ES2066096T3 (es) 4-bencil-5-fenil-2,4-dihidro-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos.
NO912942L (no) Vaksine for preventiv behandling av infeksjon av leverikte hos droevtyggere.
ES2058451T3 (es) Un metodo para la preparacion de una composicion farmaceutica.
WO1993024117A3 (en) Medicaments for the treatment of anxiety

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 471040

Country of ref document: ES